Infectious Diseases News and Research

RSS

Researchers generate reliable maps for transmission risk of Zika virus

The spread of infectious diseases such as Zika depends on many different factors. Environmental factors play a role, as do socioeconomic factors. Recently, several attempts have be made to predict the transmission risk of the Zika virus at a global and local level, but the spatial and temporal patterns of transmission are still not well understood.

11 Nov 2019

Researchers develop new, promising class of active ingredients against resistant bacteria

Researchers at the Martin Luther University Halle-Wittenberg have developed a new, promising class of active ingredients against resistant bacteria.

11 Nov 2019

Study pinpoints new weapon to fight against deadly microbes

Researchers at Monash University have gained insights into how nanoparticles could be used to identify the presence of invasive and sometimes deadly microbes, and deliver targeted treatments more effectively.

10 Nov 2019

Study finds fewer new cases of HCV in HIV-negative men who have sex with PrEP-using men

Data from a new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found fewer new cases of hepatitis C infection (commonly called HCV), despite very high rates of other sexually-transmitted infections, in HIV-negative men who have sex with men who take pre-exposure prophylaxis (PrEP) treatments.

10 Nov 2019

Illinois researchers develop lab-on-a-smartphone system to detect infectious diseases

Infectious diseases such as Zika and Dengue remain a top contributor to death and disability across the globe, according to the World Health Organization.

10 Nov 2019

Investigational vaccine protects macaques against four types of hemorrhagic fever viruses

Scientists funded by the National Institutes of Health have developed an investigational vaccine that protected cynomolgus macaques against four types of hemorrhagic fever viruses endemic to overlapping regions in Africa.

8 Nov 2019

Genetic diversity impacts efficacy of cancer immunotherapy

The constant battle against infectious pathogens has had a decisive influence on the human immune system over the course of our evolution.

8 Nov 2019

The first locally transmitted cases of Zika have been confirmed in Europe

The first native cases of Zika virus have been confirmed in Europe. Experts are calling it a wake-up call as warming global temperatures could lead to more cases across the continent.

8 Nov 2019

Understanding substantial challenges caused by substance use, misuse and dependence

This week sees publication of the first research papers that will form part of PLOS Medicine’s latest Special Issue, which is devoted to understanding the substantial challenges caused by substance use and misuse and seeking to inform responses in the health sector and beyond.

8 Nov 2019

New vaccine strategy shows promise against HIV

A collaborative team of scientists has made a successful proof-of-principle demonstration of an advanced HIV vaccine strategy--an approach that may also work in protecting people from an array of other deadly infectious diseases.

7 Nov 2019

New strain of HIV discovered and sequenced

Researchers have for the first time in twenty years come upon a new strain of HIV or Human Immunodeficiency Virus. This strain is a part of the Group M type of HIV-1. HIV-1 is the causative agent of worldwide HIV infections.

7 Nov 2019

Improved gene editing technique can successfully cut out undesirable genetic information

City of Hope researchers may have found a way to sharpen the fastest, cheapest and most accurate gene editing technique, CRISPR-Cas9, so that it can more successfully cut out undesirable genetic information.

7 Nov 2019

New model could predict response of HIV-infected individuals to cancer immunotherapy

A group of researchers at UPF and the Marchuk Institute of Numerical Mathematics in Moscow, Russia, have designed a mathematical model to predict the response of HIV-infected individuals to a type of cancer immunotherapy.

7 Nov 2019

HIV-1 virus characteristics can predict treatment efficacy with specific antibody treatment

Current HIV-1 therapies have been proven to be highly effective in slowing the progression of the virus in the body with only minimal side effects.

6 Nov 2019

New bacteria-killing toxin shows promise to impact superbug infectious diseases

An international research collaboration has discovered a new bacteria-killing toxin that shows promise of impacting superbug infectious diseases.

6 Nov 2019

People increasingly using Reddit to 'diagnose' STDs

A new study reveals that people are sharing images of their genitalia on social media in the hope of getting their sexually transmitted infections (STIs) diagnosed by others. This disturbing news not only points at rise in STIs but also misconceptions and lack of motivation to seek authentic medical advice say researchers. The study was published this week in the latest issue of the Journal of American Medical Association (JAMA).

6 Nov 2019

Risk assessment model for Ebola transmission accurately predicted Uganda cases

A new risk assessment model for the transmission of Ebola accurately predicted its spread into the Republic of Uganda, according to the Kansas State University researchers who developed it.

5 Nov 2019

Sesame allergy is common among children with other food allergies

Investigators at the National Institutes of Health have found that sesame allergy is common among children with other food allergies, occurring in an estimated 17% of this population.

4 Nov 2019

Addressing perceived stigma about taking HIV medication can help women at risk

Stigma is an important contributor to the continued HIV epidemic in the United States. While pre-exposure prophylaxis (PrEP) is a medication that can be taken to prevent HIV infection, previous research has shown that a barrier preventing gay, bisexual and other men who have sex with men from using PrEP is fear that partners, family members or community members would believe that those who use PrEP are HIV infected.

4 Nov 2019

RCSB Protein Data Bank at Rutgers receives $34.5 million funding

The RCSB Protein Data Bank headquartered at Rutgers University-New Brunswick has been awarded $34.5 million in grants over five years from three U.S. government agencies.

4 Nov 2019

Infectious Diseases News and Research

Researchers generate reliable maps for transmission risk of Zika virus

Researchers develop new, promising class of active ingredients against resistant bacteria

Study pinpoints new weapon to fight against deadly microbes

Study finds fewer new cases of HCV in HIV-negative men who have sex with PrEP-using men

Illinois researchers develop lab-on-a-smartphone system to detect infectious diseases

Investigational vaccine protects macaques against four types of hemorrhagic fever viruses

Genetic diversity impacts efficacy of cancer immunotherapy

The first locally transmitted cases of Zika have been confirmed in Europe

Understanding substantial challenges caused by substance use, misuse and dependence

New vaccine strategy shows promise against HIV

New strain of HIV discovered and sequenced

Improved gene editing technique can successfully cut out undesirable genetic information

New model could predict response of HIV-infected individuals to cancer immunotherapy

HIV-1 virus characteristics can predict treatment efficacy with specific antibody treatment

New bacteria-killing toxin shows promise to impact superbug infectious diseases

People increasingly using Reddit to 'diagnose' STDs

Risk assessment model for Ebola transmission accurately predicted Uganda cases

Sesame allergy is common among children with other food allergies

Addressing perceived stigma about taking HIV medication can help women at risk

RCSB Protein Data Bank at Rutgers receives $34.5 million funding

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News